Dr Nicole Haynes
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
25 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study
DOI: 10.1016/S1470-2045(26)00017-32026
Journal article
Striking the right balance with type I interferon signalling in cancer
DOI: 10.1038/s41568-026-00915-12025
Journal article
CAR T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
DOI: 10.1056/NEJMoa23097282024
Journal article
The complexity of immune evasion mechanisms throughout the metastatic cascade
DOI: 10.1038/s41590-024-01960-42022
Journal article
Estrogen-induced immune changes within the normal mammary gland
DOI: 10.1038/s41598-022-21871-42022
Journal article
CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors
DOI: 10.3389/fimmu.2021.8138322021
Journal article
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II) The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial
DOI: 10.1001/jamaoncol.2021.2939
RECENT SCHOLARLY WORKS
2021
Journal article
CDK4/6 inhibition promotes antitumor immunity through the induction of T-cell memory
DOI: 10.1158/2159-8290.CD-20-15542021
Journal article
Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses
DOI: 10.1016/j.ijrobp.2021.05.0142016
Conference Proceedings
Immunophenotyping breast tissue for the identification of new immune-therapeutic targets for breast cancer
RECENT PROJECTS
2016
Research Grant
The Combination of Cdk4 and Mapk/Erk Pathway Inhibitor Therapy in Melanoma: Defining Melanoma Cell Intrinsic and Immune Mediated Responses
2013
Research Grant
Building Immunity to Breast Cancer With Radio-Immunotherapy Combinations